Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Sotagliflozin vs Glimepiride or Placebo in T2D on Metformin
NCT03332771Phase 3Completed
- Sponsor
- Lexicon Pharmaceuticals, Inc.
- Start
- Dec 2017
- Primary completion
- Aug 2019
- Modality
- Small Molecules
- Countries
- 4
01
Overview
A Phase 3 trial of sotagliflozin in type 2 diabetes mellitus (T2DM), sponsored by Lexicon Pharmaceuticals, Inc.. Started Dec 2017; status: completed.
02
Drugs
sotagliflozin
03
Conditions
type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on NCT03332771.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03332771.